Vitamin D is the most commonly taken supplement in many countries. The reasoning seems solid: a large fraction of people are deficient, deficiency correlates with a huge range of health problems, and supplementing is cheap and safe. What could be complicated about this?
Quite a lot, it turns out.
Quick answer
Vitamin D matters most when someone is deficient or at high risk of deficiency. It is essential for calcium absorption and bone health, but large trials have not shown that routine supplementation in generally healthy adults prevents the broad list of diseases often implied by supplement marketing.
The useful question is not "is vitamin D good?" It is "am I deficient, at risk, or treating a specific medical problem?"
The deficiency question is contested
The definition of vitamin D deficiency has changed multiple times. The cutoff used most commonly — below 20 ng/mL — was based partly on bone health studies and partly on epidemiological associations. A 2011 report from the Institute of Medicine reviewed the evidence and concluded the widespread assumption that most people were deficient was based on a statistical error: researchers had set the "normal" range using a reference population that was itself mostly deficient.
This matters because if the threshold is wrong, the number of people classified as deficient is artificially inflated, and the apparent benefits of supplementation are partly an artifact of comparing to a flawed baseline.
What supplementation reliably does
Bone health is solid. Vitamin D is essential for calcium absorption, and supplementation reduces fracture risk in older adults who are genuinely deficient, particularly when combined with calcium. This is the original evidence base for vitamin D and it remains strong.
Immune function has a plausible mechanism and some supporting evidence. Vitamin D receptors are present in most immune cells, and severe deficiency is associated with increased infection risk. The evidence for supplementation reducing respiratory infections is modest but consistent enough that it's reasonable.
What the large trials found
The VITAL trial — one of the largest and most rigorous vitamin D supplementation studies ever conducted, with over 25,000 participants — found that 2,000 IU/day of vitamin D did not significantly reduce the incidence of cancer, cardiovascular disease, or type 2 diabetes compared to placebo. These were the outcomes that much of the observational evidence had suggested it would help with.
This is the central tension in vitamin D research: observational studies (looking at populations) show strong associations between low vitamin D and worse health outcomes across many conditions. Intervention trials (actually giving people supplements) repeatedly fail to reproduce these associations as benefits.
The most likely explanation is confounding. Low vitamin D levels are themselves a marker for other things that cause poor health — spending little time outdoors, having chronic illness, being elderly, having obesity (fat tissue sequesters vitamin D). The low vitamin D isn't causing the bad outcomes; it's a sign of conditions that do.
Who should probably supplement
People who get little sun exposure — due to geography, indoor work, or cultural practices — have a legitimate reason to supplement. Darker skin pigmentation reduces vitamin D synthesis from sunlight, making deficiency more common in South Asian and African populations living in northern latitudes. Elderly people synthesize less vitamin D from sun exposure even when exposed. People with fat malabsorption conditions (Crohn's, celiac) are at risk.
For people in these groups, supplementation is well-justified. 1,000-2,000 IU/day is generally safe and sufficient for most adults.
The upper limit matters
Unlike water-soluble vitamins, vitamin D is fat-soluble and accumulates. Chronic supplementation above 4,000 IU/day without monitoring can lead to hypercalcemia — elevated blood calcium — which causes nausea, weakness, kidney problems, and worse. The supplement industry sells doses of 5,000 and 10,000 IU as routine products. At those doses without regular blood testing, toxicity is a genuine risk.
The comfortable assumption that more is better does not apply here.
For nearby evidence guides, see magnesium supplements, creatine evidence, and GLP-1 drugs explained.